Comparative efficacy and safety of PD-1 versus PD-L1 inhibitors in breast cancer treatment: A systematic review and meta analysis. Xie X, Chen L, Kong X, Huo Y, et al. Int J Cancer 2025;156:1936-1949.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xie X, Chen L, Kong X, Huo Y, et al. Comparative efficacy and safety of PD-1 versus PD-L1 inhibitors in breast cancer treatment: A systematic review and meta analysis. Int J Cancer 2025;156:1936-1949.
PMID: 40110878